Detalhe da pesquisa
1.
Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population.
Histopathology
; 82(7): 1013-1020, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36779226
2.
Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial.
J Med Internet Res
; 23(12): e27886, 2021 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34904948
3.
Web-Based Self-Management for Patients With Lymphoma: Assessment of the Reach of Intervention of a Randomized Controlled Trial.
J Med Internet Res
; 22(5): e17018, 2020 05 14.
Artigo
Inglês
| MEDLINE | ID: mdl-32406858
4.
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies.
Ann Hematol
; 94(1): 23-34, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25096636
5.
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.
Blood Adv
; 8(5): 1094-1104, 2024 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38191686
6.
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.
J Clin Oncol
; 39(25): 2758-2767, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33945289
7.
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS.
Cancers (Basel)
; 13(4)2021 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33562393
8.
Autologous and allogeneic stem cell transplantation for myelodysplastic syndrome.
Blood Rev
; 21(1): 49-59, 2007 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-16822600
9.
Stem cell transplantation for leukemias following myelodysplastic syndromes or secondary to cytotoxic therapy.
Rev Clin Exp Hematol
; 6(1): 72-85; discussion 86-7, 2002 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-12060485
10.
The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups.
Br J Haematol
; 123(1): 81-9, 2003 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-14510946